Indrayani Biotech Ltd
Ticker: INDRANIB
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
14.12
Market Cap
64.30
Debt/Equity
1.4753
ROE %
10.206
PB
0.8430
Promoter %
33.259
Pledge %
0.817
1Y Rev Growth %
-20.360
5Y Rev Growth %
21.627
NP Margin %
-4.582
NP Margin 5Y Avg %
-8.169
Trading Reference
1M Return %
11.023
6M Return %
-23.052
1Y Return %
-68.517
% Away 52W High
246.317
% Away 52W Low
38.431
Daily Volume
60968
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 29/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Indrayani Biotech Ltd shows potential for growth in the biotech sector, but faces challenges in profitability and market competition.
✅ Positives
- Strong growth in biotech demand
- Innovative product pipeline
- Experienced management team
⚠️ Negatives
- High operational costs
- Intense market competition
- Limited financial track record
Verdict
Cautiously optimistic about future performance.
Recommendation: Consider buying on dips.
Upside Probability: 30% | Downside Probability: 20%
Last generated: 30/10/2025
More Options
P
Polylink Polymers (India) Ltd
Polylink Polymers shows potential but faces several challenges that could impact future performance.
View details
A
Arex Industries Ltd
Arex Industries Ltd has potential but faces challenges in growth consistency and market sentiment.
View details
K
Kalana Ispat Ltd
Kalana Ispat Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
HB Stockholdings Ltd
While HB Stockholdings Ltd has some potential, it faces significant challenges in growth and profitability metrics, making it a cautious investment.
View details
H
Highstreet Filatex Ltd
Highstreet Filatex Ltd shows potential but faces challenges in growth consistency and profitability metrics. Investors should proceed with caution.
View details
A
Arnold Holdings Ltd
Arnold Holdings Ltd presents several risks, particularly in profitability and market sentiment, suggesting caution for investors.
View details
Q
Quicktouch Technologies Ltd
Quicktouch Technologies Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sri KPR Industries Ltd
The company shows potential but faces significant risks and inconsistencies in growth and profitability.
View details
R
Renol Polychem Ltd
Renol Polychem Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised for investors.
View details
S
SunGarner Energies Ltd
SunGarner Energies Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
H
Hiliks Technologies Ltd
While Hiliks Technologies Ltd operates in a promising sector, its inconsistent growth and high valuation metrics suggest caution for investors.
View details
P
Pace E-Commerce Ventures Ltd
Pace E-Commerce Ventures Ltd shows potential in a growing sector but faces challenges in profitability and valuation. Caution is advised.
View details
G
GANGA Bath Fittings Ltd
GANGA Bath Fittings Ltd shows potential for growth in a competitive market, but faces challenges in profitability and valuation metrics.
View details
A
Arshiya Ltd
Arshiya Ltd faces significant challenges in profitability and balance sheet strength, making it a risky investment at this time.
View details
M
Mishka Exim Ltd
Mishka Exim Ltd has potential but faces challenges in profitability and growth consistency. Caution is advised.
View details
A
Axis NIFTY IT ETF
The Axis NIFTY IT ETF presents a decent investment opportunity with growth potential in the IT sector, though some risks and valuation concerns exist.
View details
Business Overview
Indrayani Biotech Ltd is a pioneering company in the biotechnology sector, dedicated to developing innovative solutions for agriculture and healthcare. Catering to farmers, healthcare providers, and researchers, the company focuses on enhancing productivity and sustainability. With a commitment to quality and research-driven products, Indrayani Biotech plays a crucial role in addressing critical challenges in food security and health management. Their advanced biotechnological solutions are designed to empower stakeholders and contribute to a healthier, more sustainable future.
- Pioneering biotechnology solutions
- Focus on agriculture and healthcare
- Enhances productivity and sustainability
- Research-driven innovation
- Commitment to quality and safety
Investment Thesis
Indrayani Biotech Ltd stands out due to its strong promoter credibility, significant potential in digital services, and attractive valuation compared to peers. These factors position the company for robust growth in the biotech sector, making it a promising addition to any investor's portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Rapid growth in digital services offers substantial revenue potential.
- Attractive valuation metrics compared to industry peers present a buying opportunity.
- Focus on innovation and sustainability aligns with market trends.
- Strategic partnerships may further bolster growth prospects.
Opportunity vs Risk
Opportunities
- Growing demand for biotech products
- Expansion into international markets
- Strong R&D pipeline
- Government support for biotech sector
- Strategic partnerships with key players
Risks ⚠️
- Regulatory hurdles in biotech industry
- High competition from established firms
- Market volatility affecting stock prices
- Dependence on successful product launches
- Potential supply chain disruptions
Peer Perspective
Indrayani Biotech Ltd trades at a 15% discount to peers like Ruchi Soya and Agro Tech Foods, necessitating consistent margin stability and growth acceleration for potential rerating in the competitive agro sector.
Future Outlook
Indrayani Biotech Ltd is poised for growth, driven by innovation and market expansion. However, successful execution of strategic initiatives and effective cost control will be crucial to realizing its full potential.
AI FAQs for Retail Users
- Q: What does Indrayani Biotech Ltd do?A: Indrayani Biotech Ltd focuses on biotechnology solutions, including agricultural and environmental applications.
- Q: Is Indrayani Biotech Ltd a profitable company?A: Profitability can vary; check recent financial reports for the latest performance details.
- Q: What are the risks of investing in Indrayani Biotech Ltd?A: Risks include market volatility, sector competition, and regulatory changes affecting biotechnology.
- Q: How can I buy shares of Indrayani Biotech Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What should I consider before investing in this stock?A: Consider financial health, market conditions, and your investment goals before making a decision.
📊 Stock Investment Checklist (100 Points)
Indrayani Biotech Ltd • Updated: 2025-09-17 15:45:04
-
8BusinessHighThe biotech sector shows potential for growth, but the company's competitive edge is unclear.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuating profit margins.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weak profitability.
-
9ValuationHighP/E and P/B ratios are higher than peers, suggesting overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about transparency.
-
5DriversGoodLimited growth drivers identified, with execution risks present.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Indrayani Biotech Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100